MD
Menka Devi
About Menka Devi
Data last updated:
Menka Devi has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Nikkon Lifescience Private Limited and Medimart Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Nikkon Lifescience Private Limited at ₹4.01 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nikkon Lifescience Private Limited U24302KA2018PTC115362 | Director | 09 Aug 2018 | 2018 | ₹4.01 Cr (FY 2025) | Active |
| Medimart Pharma Private Limited U51902BR2016PTC031833 | Director | 20 Jun 2016 | 2016 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Menka Devi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Menka Devi
Menka Devi has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Nikkon Lifescience Private Limited and Medimart Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Nikkon Lifescience Private Limited at ₹4.01 Cr (FY 2025).
Menka Devi is associated with 2 companies as Director, including Nikkon Lifescience Private Limited (₹4.01 Cr), Medimart Pharma Private Limited.
Menka Devi has expertise in General Business.
Menka Devi has 10 years in corporate governance.
By reported revenue, the largest current company of Menka Devi is Nikkon Lifescience Private Limited, with revenue of ₹4.01 Cr (FY 2025).
Menka Devi currently holds positions at 2 companies: Nikkon Lifescience Private Limited (₹4.01 Cr), Medimart Pharma Private Limited.